Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Audrey Umbreit"'
Publikováno v:
INNOVATIONS in Pharmacy, Vol 15, Iss 2 (2024)
Background: Pharmacogenomics (PGx) is a tool to guide optimal medication selection. Increased demand for personalized medicine and the growing occurrence of chronic diseases are drivers for pharmacogenomic medication management services. A review of
Externí odkaz:
https://doaj.org/article/e90b7de1974146f9857ce32b1bf2b267
Autor:
Kelsey Mews, Audrey Umbreit, Emily Holm, Kelsie Davis, Ellen Kelly, Carson Reinhardt, Allison Young, Joseph Flynn
Publikováno v:
INNOVATIONS in Pharmacy, Vol 13, Iss 1 (2022)
Purpose: To assess the impact of a pharmacist-led warfarin to DOAC conversion initiative during the COVID-19 pandemic. Methods: Patients who were prescribed warfarin and followed with the anticoagulation clinic for INR monitoring were assessed by o
Externí odkaz:
https://doaj.org/article/f3884b7553194f4f8ca817606ed8d267
Publikováno v:
INNOVATIONS in Pharmacy, Vol 12, Iss 3 (2021)
Purpose. To describe the employment of an automated text messaging text-bot during the 2019 American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting Residency Showcase and its impact on the number of applications received for the
Externí odkaz:
https://doaj.org/article/6aef130b34764f26a8d0872540bbe5fa
Publikováno v:
Journal of Primary Care & Community Health, Vol 12 (2021)
Treatment resistant restless legs syndrome (RLS) in the setting of psychiatric comorbidities can be difficult to manage. Our patient is a 69-year-old Caucasian gentleman with bipolar disorder type I, unspecified anxiety disorder, obstructive sleep ap
Externí odkaz:
https://doaj.org/article/3eca0af21d2e40d3b3fab9d5e83749c6
Autor:
Bhanu Prakash Kolla, Jeremiah Fairbanks, Victor M. Karpyak, Larissa L. Loukianova, Shirshendu Sinha, Audrey Umbreit, Terry D. Schneekloth
Publikováno v:
Mayo Clinic Proceedings. 95:1964-1977
Pathologic alcohol use affects more than 2 billion people and accounts for nearly 6% of all deaths worldwide. There are three medications approved for the treatment of alcohol use disorder by the US Food and Drug Administration (FDA): disulfiram, nal
Autor:
Liewei Wang, Steven E. Scherer, Suzette J. Bielinski, Donna M. Muzny, Leila A. Jones, John Logan Black, Ann M. Moyer, Jyothsna Giri, Richard R. Sharp, Eric T. Matey, Jessica A. Wright, Lance J. Oyen, Wayne T. Nicholson, Mathieu Wiepert, Terri Sullard, Timothy B. Curry, Carolyn R. Rohrer Vitek, Tammy M. McAllister, Jennifer L. St. Sauver, Pedro J. Caraballo, Konstantinos N. Lazaridis, Eric Venner, Xiang Qin, Jianhong Hu, Christie L. Kovar, Viktoriya Korchina, Kimberly Walker, HarshaVardhan Doddapaneni, Tsung-Jung Wu, Ritika Raj, Shawn Denson, Wen Liu, Gauthami Chandanavelli, Lan Zhang, Qiaoyan Wang, Divya Kalra, Mary Beth Karow, Kimberley J. Harris, Hugues Sicotte, Sandra E. Peterson, Amy E. Barthel, Brenda E. Moore, Jennifer M. Skierka, Michelle L. Kluge, Katrina E. Kotzer, Karen Kloke, Jessica M. Vander Pol, Heather Marker, Joseph A. Sutton, Adrijana Kekic, Ashley Ebenhoh, Dennis M. Bierle, Michael J. Schuh, Christopher Grilli, Sara Erickson, Audrey Umbreit, Leah Ward, Sheena Crosby, Eric A. Nelson, Sharon Levey, Michelle Elliott, Steve G. Peters, Naveen Pereira, Mark Frye, Fadi Shamoun, Matthew P. Goetz, Iftikhar J. Kullo, Robert Wermers, Jan A. Anderson, Christine M. Formea, Razan M. El Melik, John D. Zeuli, Joseph R. Herges, Carrie A. Krieger, Robert W. Hoel, Jodi L. Taraba, Scott R. St. Thomas, Imad Absah, Matthew E. Bernard, Stephanie R. Fink, Andrea Gossard, Pamela L. Grubbs, Therese M. Jacobson, Paul Takahashi, Sharon C. Zehe, Susan Buckles, Michelle Bumgardner, Colette Gallagher, Kelliann Fee-Schroeder, Nichole R. Nicholas, Melody L. Powers, Ahmed K. Ragab, Darcy M. Richardson, Anthony Stai, Jaymi Wilson, Joel E. Pacyna, Janet E. Olson, Erica J. Sutton, Annika T. Beck, Caroline Horrow, Krishna R. Kalari, Nicholas B. Larson, Hongfang Liu, Liwei Wang, Guilherme S. Lopes, Bijan J. Borah, Robert R. Freimuth, Ye Zhu, Debra J. Jacobson, Matthew A. Hathcock, Sebastian M. Armasu, Michaela E. McGree, Ruoxiang Jiang, Tyler H. Koep, Jason L. Ross, Matthew G. Hilden, Kathleen Bosse, Bronwyn Ramey, Isabelle Searcy, Eric Boerwinkle, Richard A. Gibbs, Richard M. Weinshilboum
Publikováno v:
Genet Med
PURPOSE: The Mayo-Baylor RIGHT 10K Study enabled preemptive, sequence-based pharmacogenomics (PGx)-driven drug prescribing practices in routine clinical care within a large cohort. We also generated the tools and resources necessary for clinical PGx
Publikováno v:
INNOVATIONS in Pharmacy, Vol 12, Iss 3 (2021)
Purpose. To describe the employment of an automated text messaging text-bot during the 2019 American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting Residency Showcase and its impact on the number of applications received for the
Autor:
Ross A. Dierkhising, Sarah A. McGill, Jordan D. Haag, Kaitlin J. Yost, Amy L. Rantala, Jay D. Mitchell, Kimberly A. Kosloski Tarpenning, Nilay Shah, James A. Storlie, Audrey Umbreit
Publikováno v:
Journal of the American Board of Family Medicine : JABFM. 34(3)
Purpose: As the prevalence of provider burnout continues to increase, it is critical to identify interventions that may impact provider satisfaction, such as an integrated clinical pharmacist. This study aimed to assess the perceived effect of pharma
Autor:
Shirshendu Sinha, Victor M. Karpyak, Jeremiah Fairbanks, Audrey Umbreit, Terry D. Schneekloth, Larissa L. Loukianova, Bhanu Prakash Kolla
Publikováno v:
Mayo Clinic Proceedings. 95:2295-2296
Publikováno v:
Journal of Primary Care & Community Health, Vol 12 (2021)
Journal of Primary Care & Community Health
Journal of Primary Care & Community Health
Treatment resistant restless legs syndrome (RLS) in the setting of psychiatric comorbidities can be difficult to manage. Our patient is a 69-year-old Caucasian gentleman with bipolar disorder type I, unspecified anxiety disorder, obstructive sleep ap